Is calculated LDL-C by using the new modified Friedewald equation better than the standard Friedewald equation?

Journal of the Medical Association of Thailand

Volumn 87, Issue 6, 2004, Pages 589-593

  Puavilai, Wilai ^a   Laoragpongse, Donpichit ^a  

^a RAJAVITHI HOSPITAL   (Thailand)

Author keywords

Ban Paew Project; Calculating LDL C; Friedewald equation; New modified Friedewald equation

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; ADULT; AGED; ARTICLE; CALCULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; CORRELATION ANALYSIS; DYSLIPIDEMIA; FRIEDEWALD EQUATION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; PREDICTION AND FORECASTING; STATISTICS;

CHI-SQUARE DISTRIBUTION; CHOLESTEROL, LDL; HUMANS; PREDICTIVE VALUE OF TESTS; STATISTICS; TRIGLYCERIDES;

EID: 3543049443     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA, 2001; 285: 2486-97.
2. Smilde TJ, Wissen S van, Wollersheim H, Trip MD, Kastelein JJ P, Stalenhoef AFH. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP) a prospective, randomized double - blind trial. Lancet 2001; 357: 577-81.
3. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K, together with members of the task force. Task force report. Prevention of coronary heart disease in clinical practice, recommendations of the School Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998; 140: 199-270.
4. The Post Coronary Artery Bypass Graft Trial Investigations. The effect of aggressive lowering of low-density lipoprotein cholesterol level and coronary artery bypass graft. N Engl J Med 1997; 336: 153-62
5. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease The Scandinavian Simvastation Survival Study (4S). Lancet 1994; 344: 1383-9.
6. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, et al. For the Atorvastatin versus Revascularization Treatment Investigators. Aggressive Lipid lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999; 341: 70-6.
7. National Heart Lung and Blood Institute (NHLBI) Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. The Evidence Report. Bethesda; MD: National Institutes of Health, NHLBI; 1998.
8. Turpeinen O. Effect of cholesterol-lowering diet on mortality from coronary heart disease. Circulation 1979; 59: 1-7.
9. Wenger NK, Froelicher ES, Smith LK. Cardiac Rehabilitation as Secondary Prevention. Bethesda, MD: National Heart, Lung and Blood Institute; 1995.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.
11. Benlian P, Cansier C, Hennache G, Khallouf O, Bayer P, et al. Comparison of a New Method for the Direct and Simultaneous Assessment of LDL- and HDL-Cholesterol with Ultracentrifugation and Established Methods. Clin Chem 2000; 46: 493-505.
12. Nauck M, Warnick GR and Rifai N. Methods for Measurement of LDL-cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assay versus Calculation. Clin Chem 2002; 48: 236-54.